|
Differential recovery of ventricular repolarization and hemodynamics following bupivacaine and ropivacaine intoxication: the impact of lipophilicity on lipid emulsion efficacy.
PMID 42394973 · Front Pharmacol · 2026
未发现恶性肿瘤人群证据。
|
H
|
仅历史库存 |
excludednon_oncology |
pending
0 Figure · 0 Panel · risk -
|
|
Long-term use of rozanolixizumab in generalised myasthenia gravis: final pooled analysis of the phase III MycarinG study and two open-label extensions.
PMID 42388397 · Ther Adv Neurol Disord · 2026
未发现恶性肿瘤人群证据。
|
H
|
仅历史库存 |
excludednon_oncology |
pending
0 Figure · 0 Panel · risk -
|
|
Content Validity and Psychometric Evaluation of the Idiopathic Hypersomnia Severity Scale (IHSS) in Adults with Idiopathic Hypersomnia.
PMID 42382222 · Nat Sci Sleep · 2026
未发现恶性肿瘤人群证据。
|
H
|
仅历史库存 |
excludednon_oncology |
pending
0 Figure · 0 Panel · risk -
|
|
Study protocol for a prospective, cluster randomised control, hybrid type 1 effectiveness-implementation trial to evaluate the Reduction Of Seizures through Education and Support: the ROSES study.
PMID 42367638 · BMJ Neurol Open · 2026
方案论文未报告临床试验结果。
|
H
|
仅历史库存 |
excludedprotocol_without_results |
pending
0 Figure · 0 Panel · risk -
|
|
Optimal exercise prescription for patients with coronary heart disease across cardiac rehabilitation phases: a systematic review and network meta-analysis.
PMID 42367338 · Front Sports Act Living · 2026
记录类型属于综述、Meta 分析、社论、评论、病例或指南。
|
H
|
仅历史库存 |
excludedexcluded_publication_type |
pending
0 Figure · 0 Panel · risk -
|
|
Vaccines as treatment for melanoma: an update review.
PMID 42344931 · Front Immunol · 2026
记录类型属于综述、Meta 分析、社论、评论、病例或指南。
|
H
S
B
|
严格 v3 独有 |
excludedexcluded_publication_type |
pending
0 Figure · 0 Panel · risk -
|
|
Efficacy of Adjunctive Lumateperone 42 mg on Anhedonia and Across a Broad Range of Depressive Symptoms in Major Depressive Disorder: Post Hoc Analysis of a Phase 3, Randomized, Placebo-Controlled Trial.
PMID 42344568 · Neuropsychiatr Dis Treat · 2026
属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。
|
H
|
仅历史库存 |
excludedpost_hoc_or_secondary_analysis |
pending
0 Figure · 0 Panel · risk -
|
|
An MR-Neuroimaging Study of Structural and Vascular Brain Networks in Elderly Adults with Obesity and Diabetes who Practice Structural Yoga.
PMID 42344431 · F1000Res · 2026
未发现恶性肿瘤人群证据。
|
H
|
仅历史库存 |
excludednon_oncology |
pending
0 Figure · 0 Panel · risk -
|
|
Glucagon-like peptide-1 receptor agonists in movement disorders: From Parkinson's disease to the broader spectrum - Mechanisms, evidence, and future directions.
PMID 42328044 · Clin Park Relat Disord · 2026
记录类型属于综述、Meta 分析、社论、评论、病例或指南。
|
H
|
仅历史库存 |
excludedexcluded_publication_type |
pending
0 Figure · 0 Panel · risk -
|
|
Comparative efficacy and safety of first-line treatments for advanced hepatocellular carcinoma: a Bayesian network meta-analysis.
PMID 42327777 · Front Immunol · 2026
记录类型属于综述、Meta 分析、社论、评论、病例或指南。
|
H
S
B
|
严格 v3 独有 |
excludedexcluded_publication_type |
pending
0 Figure · 0 Panel · risk -
|
|
Updating the MASH pharmacotherapy landscape: a network meta-analysis incorporating SGLT2 inhibitors and emerging combination therapies.
PMID 42325618 · Front Endocrinol (Lausanne) · 2026
记录类型属于综述、Meta 分析、社论、评论、病例或指南。
|
H
|
仅历史库存 |
excludedexcluded_publication_type |
pending
0 Figure · 0 Panel · risk -
|
|
Effect of histology on the efficacy of first-line immune checkpoint inhibitors in advanced non-small cell lung cancer: a systematic review and network meta-analysis.
PMID 42317330 · Front Immunol · 2026
记录类型属于综述、Meta 分析、社论、评论、病例或指南。
|
H
S
B
|
严格 v3 独有 |
excludedexcluded_publication_type |
pending
0 Figure · 0 Panel · risk -
|
|
Effectiveness and implementation of a primary healthcare intervention for multimorbidity and frailty among urban older adults in India: Protocol for the Multi-FrAME cluster randomized trial.
PMID 42313862 · PLoS One · 2026
方案论文未报告临床试验结果。
|
H
|
仅历史库存 |
excludedprotocol_without_results |
pending
0 Figure · 0 Panel · risk -
|
|
Aprocitentan: An oral, once-daily antihypertensive therapy for resistant hypertension in adult patients.
PMID 42293060 · Heart Int · 2026
记录类型属于综述、Meta 分析、社论、评论、病例或指南。
|
H
|
仅历史库存 |
excludedexcluded_publication_type |
pending
0 Figure · 0 Panel · risk -
|
|
Impact of time-of-day on immune checkpoint inhibitor therapy in cancer patients: an up-to-date clinical review.
PMID 42292486 · Front Immunol · 2026
记录类型属于综述、Meta 分析、社论、评论、病例或指南。
|
H
B
|
仅广召回影子组 |
excludedexcluded_publication_type |
pending
0 Figure · 0 Panel · risk -
|
|
Rapid Onset of Response in Adults with Dermatomyositis Receiving Dazukibart: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study.
PMID 42273013 · Clin Cosmet Investig Dermatol · 2026
属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。
|
H
|
仅历史库存 |
excludedpost_hoc_or_secondary_analysis |
pending
0 Figure · 0 Panel · risk -
|
|
From concept to clinical practice: the evolution of low- and ultra-low-dose triple combination therapy for hypertension.
PMID 42261276 · Clin Hypertens · 2026
记录类型属于综述、Meta 分析、社论、评论、病例或指南。
|
H
|
仅历史库存 |
excludedexcluded_publication_type |
pending
0 Figure · 0 Panel · risk -
|
|
Clinical trial evidence on emerging pharmacological therapies for hypoactive sexual desire disorder in women: a systematic review and analysis of completed studies registered on ClinicalTrials.gov.
PMID 42254382 · Front Med (Lausanne) · 2026
记录类型属于综述、Meta 分析、社论、评论、病例或指南。
|
H
|
仅历史库存 |
excludedexcluded_publication_type |
pending
0 Figure · 0 Panel · risk -
|
|
Real-World Data on the Use of Follitropin Delta in a Dutch IVF Center.
PMID 42253904 · Reprod Med Biol · 2026
未发现恶性肿瘤人群证据。
|
H
|
仅历史库存 |
excludednon_oncology |
pending
0 Figure · 0 Panel · risk -
|
|
Efficacy and safety of upadacitinib in the treatment of rheumatoid arthritis: a systematic review and meta-analysis.
PMID 42245676 · Front Immunol · 2026
记录类型属于综述、Meta 分析、社论、评论、病例或指南。
|
H
|
仅历史库存 |
excludedexcluded_publication_type |
pending
0 Figure · 0 Panel · risk -
|
|
Adapting, piloting, and evaluating a pediatric lead screening and risk-reduction intervention in Nairobi: A hybrid implementation-effectiveness trial protocol.
PMID 42241430 · PLoS One · 2026
方案论文未报告临床试验结果。
|
H
|
仅历史库存 |
excludedprotocol_without_results |
pending
0 Figure · 0 Panel · risk -
|
|
Serplulimab combined with gemcitabine, nab-paclitaxel, and stereotactic body radiotherapy versus gemcitabine and nab-paclitaxel as first-line treatment for recurrent or metastatic pancreatic ductal adenocarcinoma: a randomized, open-label, multicenter, phase III clinical trial (WGOG-PAN 006/ICSBR-2).
PMID 42212134 · Front Immunol · 2026
明确的 Phase III/IIIb/II-III 随机肿瘤药物试验,且报告 time-to-event 结局。
|
H
S
B
|
严格 v3 独有 |
eligibleexplicit_phase3_randomized |
no_km
0 Figure · 0 Panel · risk not_applicable
|
|
Limited benefits of neoadjuvant therapy on R0 resection rate and overall survival in patients with resectable or locally advanced PDAC in randomized controlled trials.
PMID 42210933 · Front Med (Lausanne) · 2026
记录类型属于综述、Meta 分析、社论、评论、病例或指南。
|
H
S
B
|
严格 v3 独有 |
excludedexcluded_publication_type |
pending
0 Figure · 0 Panel · risk -
|
|
Effects of taurine supplementation on metabolic health and biological aging in healthcare workers: A protocol for a triple-blinded, Bayesian-optimized phase II randomized controlled trial.
PMID 42201902 · PLoS One · 2026
方案论文未报告临床试验结果。
|
H
|
仅历史库存 |
excludedprotocol_without_results |
pending
0 Figure · 0 Panel · risk -
|
|
TROPION-Lung14 study protocol: a phase III study of osimertinib in combination with datopotamab deruxtecan versus osimertinib alone as first-line treatment for patients with EGFR-mutated locally advanced or metastatic non-small cell lung cancer.
PMID 42182601 · Ther Adv Med Oncol · 2026
方案论文未报告临床试验结果。
|
H
S
B
|
严格 v3 独有 |
excludedprotocol_without_results |
pending
0 Figure · 0 Panel · risk -
|
|
Comparative Effectiveness of Cytisinicline and Varenicline for Smoking Cessation: A Matching-Adjusted Indirect Comparison (MAIC).
PMID 42180667 · J Health Econ Outcomes Res · 2026
未发现恶性肿瘤人群证据。
|
H
|
仅历史库存 |
excludednon_oncology |
pending
0 Figure · 0 Panel · risk -
|
|
Efficacy and safety of first-line osimertinib monotherapy versus osimertinib plus platinum-based chemotherapy or amivantamab plus lazertinib in metastatic EGFR-mutated NSCLC: an indirect comparison.
PMID 42180117 · Front Oncol · 2026
明确的 Phase III/IIIb/II-III 随机肿瘤药物试验,且报告 time-to-event 结局。
|
H
S
B
|
严格 v3 独有 |
eligibleexplicit_phase3_randomized |
confirmed
3 Figure · 6 Panel · risk visible
|
|
Sports-based mental health promotion for adolescents in rural Nepal: A pilot cluster-randomised controlled trial.
PMID 42149858 · PLOS Glob Public Health · 2026
未发现恶性肿瘤人群证据。
|
H
|
仅历史库存 |
excludednon_oncology |
pending
0 Figure · 0 Panel · risk -
|
|
Co-creation of a mobile health program (MumCare) for preventing maternal cardiovascular disease after pregnancy complications.
PMID 42145904 · Front Glob Womens Health · 2026
未发现恶性肿瘤人群证据。
|
H
|
仅历史库存 |
excludednon_oncology |
pending
0 Figure · 0 Panel · risk -
|
|
Correction to "Tegoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial".
PMID 42141840 · Helicobacter · 2026
未发现恶性肿瘤人群证据。
|
H
|
仅历史库存 |
excludednon_oncology |
pending
0 Figure · 0 Panel · risk -
|
|
Pattern of resistance on first-line EGFR-directed therapy in EGFR-positive metastatic NSCLC.
PMID 42131879 · Ecancermedicalscience · 2026
属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。
|
H
S
B
|
严格 v3 独有 |
excludedpost_hoc_or_secondary_analysis |
pending
0 Figure · 0 Panel · risk -
|
|
Phase III, randomized, single blind, comparative safety, and efficacy trial of intravenous iron isomaltoside (i3R) and ferric carboxy maltose in subjects with iron deficiency anaemia.
PMID 42111869 · Med J Armed Forces India · 2026
属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。
|
H
|
仅历史库存 |
excludedpost_hoc_or_secondary_analysis |
pending
0 Figure · 0 Panel · risk -
|
|
Efficacy of immunotherapy and targeted therapy for unresectable hepatocellular carcinoma: analysis of survival curves.
PMID 42110472 · Front Med (Lausanne) · 2026
明确的 Phase III/IIIb/II-III 随机肿瘤药物试验,且报告 time-to-event 结局。
|
H
S
B
|
严格 v3 独有 |
eligibleexplicit_phase3_randomized |
needs_review
2 Figure · 5 Panel · risk not_visible
|
|
Cost-utility and price threshold analysis of sacituzumab tirumotecan versus single-agent chemotherapy for previously treated metastatic triple-negative breast cancer in China.
PMID 42110256 · Front Public Health · 2026
属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。
|
H
S
B
|
严格 v3 独有 |
excludedpost_hoc_or_secondary_analysis |
pending
0 Figure · 0 Panel · risk -
|
|
Efficacy and Descriptive Safety Assessment of Programmed Cell Death Protein-(Ligand) 1 Inhibitors Plus Chemotherapy as First-Line Treatment for Gastric and Gastroesophageal Junction Cancer in Asian and Non-Asian Patients: A Meta-Analysis.
PMID 42109272 · Gastro Hep Adv · 2026
记录类型属于综述、Meta 分析、社论、评论、病例或指南。
|
H
S
B
|
严格 v3 独有 |
excludedexcluded_publication_type |
pending
0 Figure · 0 Panel · risk -
|
|
The therapeutic potential of epimedium and its bioactive flavonoids in hepatitis and cirrhosis: an integrative review.
PMID 42100655 · Front Cell Infect Microbiol · 2026
记录类型属于综述、Meta 分析、社论、评论、病例或指南。
|
H
B
|
仅广召回影子组 |
excludedexcluded_publication_type |
pending
0 Figure · 0 Panel · risk -
|
|
Efficacy and safety of first-line therapies for persistent, recurrent, or metastatic cervical cancer: a systematic review and exploratory network meta-analysis of immunotherapy.
PMID 42079658 · Front Immunol · 2026
记录类型属于综述、Meta 分析、社论、评论、病例或指南。
|
H
S
B
|
严格 v3 独有 |
excludedexcluded_publication_type |
pending
0 Figure · 0 Panel · risk -
|
|
Linzagolix, with and without add-back therapy, in women with endometriosis-associated pain: results from EDELWEISS 6, a double-blind randomized extension and withdrawal study.
PMID 42077502 · Hum Reprod Open · 2026
未发现恶性肿瘤人群证据。
|
H
|
仅历史库存 |
excludednon_oncology |
pending
0 Figure · 0 Panel · risk -
|
|
The Role of Immunotherapy in Resectable Non-Small Cell Lung Cancer.
PMID 42065071 · Oncol Res · 2026
记录类型属于综述、Meta 分析、社论、评论、病例或指南。
|
H
S
B
|
严格 v3 独有 |
excludedexcluded_publication_type |
pending
0 Figure · 0 Panel · risk -
|
|
Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: A Meta-Analysis of All Randomized Clinical Trials with Subgroup Analysis by Patient Profile.
PMID 42065038 · Oncol Res · 2026
记录类型属于综述、Meta 分析、社论、评论、病例或指南。
|
H
S
B
|
严格 v3 独有 |
excludedexcluded_publication_type |
pending
0 Figure · 0 Panel · risk -
|
|
KRASG12C inhibitors versus chemotherapy alone for KRASG12C-mutated non-small cell lung cancer: a pooled analysis of CodeBreaK 200 and KRYSTAL-12 trials.
PMID 42063697 · Front Oncol · 2026
记录类型属于综述、Meta 分析、社论、评论、病例或指南。
|
H
S
B
|
严格 v3 独有 |
excludedexcluded_publication_type |
pending
0 Figure · 0 Panel · risk -
|
|
Effects of lemborexant and zolpidem on sleep electroencephalography in older adults with insomnia: a randomized trial.
PMID 42052562 · Sleep Adv · 2026
未发现恶性肿瘤人群证据。
|
H
|
仅历史库存 |
excludednon_oncology |
pending
0 Figure · 0 Panel · risk -
|
|
Brexpiprazole for Agitation in Patients with Alzheimer's Dementia with and without Co-Occurring Psychosis: Post Hoc Analysis of Short- and Long-Term Trials.
PMID 42052145 · Neuropsychiatr Dis Treat · 2026
属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。
|
H
|
仅历史库存 |
excludedpost_hoc_or_secondary_analysis |
pending
0 Figure · 0 Panel · risk -
|
|
CALGB 140503 and the shift to sublobar resection for small, peripheral, node-negative NSCLC: historical context, secondary analyses, and next steps.
PMID 42038383 · Front Oncol · 2026
记录类型属于综述、Meta 分析、社论、评论、病例或指南。
|
H
S
B
|
严格 v3 独有 |
excludedexcluded_publication_type |
pending
0 Figure · 0 Panel · risk -
|
|
De-escalation of head-and-neck cancer radiotherapy: balancing cure and side effects.
PMID 42038372 · Front Oncol · 2026
记录类型属于综述、Meta 分析、社论、评论、病例或指南。
|
H
S
B
|
严格 v3 独有 |
excludedexcluded_publication_type |
pending
0 Figure · 0 Panel · risk -
|
|
Efficacy and Safety of Preservative-Free Bimatoprost 0.01% Gel in Patients with Open-Angle Glaucoma and Ocular Hypertension: Results from Two Phase III Randomized Trials.
PMID 42004641 · Clin Ophthalmol · 2026
未发现恶性肿瘤人群证据。
|
H
|
仅历史库存 |
excludednon_oncology |
pending
0 Figure · 0 Panel · risk -
|
|
Tirzepatide in Metabolically Dysfunctional-Associated Steatohepatitis (MASH): A Bibliometric and Evidence-Based Review.
PMID 41964153 · J Diabetes Res · 2026
记录类型属于综述、Meta 分析、社论、评论、病例或指南。
|
H
|
仅历史库存 |
excludedexcluded_publication_type |
pending
0 Figure · 0 Panel · risk -
|
|
Evolving therapeutic pipeline for tumor-infiltrating lymphocytes in metastatic melanoma - a review.
PMID 41958653 · Front Immunol · 2026
记录类型属于综述、Meta 分析、社论、评论、病例或指南。
|
H
S
B
|
严格 v3 独有 |
excludedexcluded_publication_type |
pending
0 Figure · 0 Panel · risk -
|
|
Repeated lower extremities hot water bathing (REHAB), a rehabilitative strategy in Parkinson's disease (PD) patients with sleep disorders: rationale, design and protocol for a randomized controlled study.
PMID 41952857 · Front Neurol · 2026
方案论文未报告临床试验结果。
|
H
|
仅历史库存 |
excludedprotocol_without_results |
pending
0 Figure · 0 Panel · risk -
|
|
Efficacy and Clinical Relevance of Adjunctive Cariprazine Treatment in Patients with Major Depressive Disorder: Post Hoc Analyses from a Phase III Study.
PMID 41948533 · Neuropsychiatr Dis Treat · 2026
属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。
|
H
|
仅历史库存 |
excludedpost_hoc_or_secondary_analysis |
pending
0 Figure · 0 Panel · risk -
|